Am Heart J 126(4):10211024 Elliott AD et al (2021) Factors contributing to exercise intolerance in patients with atrial fibrillation
Online research about one national pharmacy a MICA member was considering revealed unsatisfactory inspections by both the FDA and state regulators related to quality concerns
Pfizer, Amgen, and dozens of smaller biotechs are racing to develop GLP-1 alternatives
The compounding landscape for oral GLP-1 formulations continues to evolve, and glycine inclusion in oral formulations may emerge as formulation science advances
Its action is mediated by a specific GLP-1 receptor
Conventionally, thresholds for low, moderate, and substantial heterogeneity are established as I 2 values of 25%, 50%, and 75%, respectively [23]